| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Networking -- How to Miss an Opportunity |
|
Useful Advices - Networking -- How to Miss an Opportunity
In a good relationship between friends it is possible that, for instance, the two friends will not see each other for quite a whi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product le. The relation can take it. Both lives can take a different turn; one has a new job, the other a new relation and for some peri ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in d both have less contact. But after a while you meet again, and the friendship is as ever before. Networking is not quite like t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. is. Take for instance this example; two people know each other for quite some time. They have exchange links on a mutual business here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe network -- LinkedIn or openBC -– but they haven't met lately. But then, all of a sudden... ... someone else connected to Linked d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro n, who is linked to “Eric” -- to give him a name -- requests to be introduced to the network of the other -- “John”. Eric thinks ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc that he knows John well enough and reckons that he can forward the request (which is a normal e-mail on LinkedIn) to John, He add easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi a little note and clicks on “SEND.” After a day when he doesn’t get notified, he wonders whether this action has been settled. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically o he enters the network site and checks the connections. No change.
“Could it be possible,” he wonders, “that John didn’t accept and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ my mediation?”
There is always this chance. So, the next day he checks again, just to be sure ... And indeed, Johns networks has ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi been extended, by -- one connection -- but more details show that this new contact is not the invitation from Eric. “This is wei ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rd,” thinks Eric and he decides to give John a call. But at the same moment he understands that he has already lost an opportunit dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod , because he should have called before. But ... as we all know, you are busy, and you fail to reserve the right amount of priorit cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to this kind of issues ... “Hi John,” - Amazing, Eric, that has been quite some while! I just saw an e-mail from you recently. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . Both talk a bit, and John explains that he has sent an e-mail to Eric’s contact, requesting for some more information. “I want t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d to challenge him a bit,” John said to Eric, "... what he wanted to achieve with this connection?" “Yes,” Eric replies, “but th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust is means that you have rejected me as a trusted source!” Would you have done the same when the president of your company would ha y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e passed a contact to you, the way I did?” But the moment Eric is telling this, he knows that there is no point. In fact he real . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de zes that he should have phoned John before sending him the link. That was the ultimate opportunity to get back in contact and to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip trengthen the relation. All else is second best... Eric will know this for the next time. A missed opportunity. © 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Growing Your Meeting In CyberSpace Is the Role of Marketing Changing Sports Marketing - Find Out Why More and More Companies are Choosing It
|